{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:22:23Z","timestamp":1792416143575,"version":"4.4.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/rhu.0b013e3181960483","type":"journal-article","created":{"date-parts":[[2009,1,8]],"date-time":"2009-01-08T08:13:47Z","timestamp":1231402427000},"page":"31-34","source":"Crossref","is-referenced-by-count":9,"title":["Tumor-Induced Osteomalacia"],"prefix":"10.1097","volume":"15","author":[{"given":"Birgit","family":"Harbeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Sch\u00f6cklmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Seekamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Czech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"M\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210207","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1056\/NEJM199406093302310","article-title":"Tumor-induced osteomalacia-unveiling a new hormone.","volume":"330","author":"Econs","year":"1994","journal-title":"N Engl J Med"},{"key":"R2-10-20210207","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ndt\/12.1.11","article-title":"Phosphatonin\u2013a new phosphaturetic hormone? (Lessons from tumour-induced osteomalacia and X-linked hypophosphataemia.)","volume":"12","author":"Kumar","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"R3-10-20210207","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJM199406093302304","article-title":"Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia.","volume":"330","author":"Cai","year":"1994","journal-title":"N Engl J Med"},{"key":"R4-10-20210207","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/geno.2000.6235","article-title":"MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia.","volume":"67","author":"Rowe","year":"2000","journal-title":"Genomics"},{"key":"R5-10-20210207","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI18563","article-title":"Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent.","volume":"112","author":"Berndt","year":"2003","journal-title":"J Clin Invest"},{"key":"R6-10-20210207","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"key":"R7-10-20210207","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","article-title":"Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23.","volume":"60","author":"White","year":"2001","journal-title":"Kidney Int"},{"key":"R8-10-20210207","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2265.2001.01056.x","article-title":"Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy.","volume":"54","author":"Rhee","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R9-10-20210207","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(02)07846-7","article-title":"Localisation of mesenchymal tumours by somatostatin receptor imaging.","volume":"359","author":"Jan de Beur","year":"2002","journal-title":"Lancet"},{"key":"R10-10-20210207","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa010839","article-title":"Octreotide therapy for tumor-induced osteomalacia.","volume":"345","author":"Seufert","year":"2001","journal-title":"N Engl J Med"},{"key":"R11-10-20210207","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00003072-199902000-00016","article-title":"Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia.","volume":"24","author":"Nguyen","year":"1999","journal-title":"Clin Nucl Med"},{"key":"R12-10-20210207","first-page":"1922","article-title":"Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification.","volume":"56","author":"Reubi","year":"1996","journal-title":"Cancer Res"},{"key":"R13-10-20210207","first-page":"934","article-title":"Hypophosphataemic osteomalacia misdiagnosed as metastatic carcinoma.","volume":"67","author":"O\u2019Donnell","year":"1985","journal-title":"S Afr Med J"},{"key":"R14-10-20210207","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/rheumatology\/39.12.1415","article-title":"Four cases of acquired hypophosphataemic (\u201concogenic\u201d) osteomalacia. Problems of diagnosis, treatment and long-term management.","volume":"39","author":"Clunie","year":"2000","journal-title":"Rheumatology"},{"key":"R15-10-20210207","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00774-004-0594-z","article-title":"Hypophosphatemic osteomalacia: a report of five cases and evaluation of bone markers.","volume":"23","author":"Ros","year":"2005","journal-title":"J Bone Miner Metab"},{"key":"R16-10-20210207","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1136\/bmj.1.5399.1672-a","article-title":"Hypophosphataemic osteomalacia with complete recovery.","volume":"1","author":"Dent","year":"1964","journal-title":"Br Med J"},{"key":"R17-10-20210207","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.rhu.0000101906.15276.ed","article-title":"Oncogenic hypophospatemic osteomalacia associated with a nasal hemangioperiytoma.","volume":"9","author":"Fuentealba","year":"2003","journal-title":"J Clin Rheumatol"},{"key":"R18-10-20210207","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","article-title":"Tumor-induced osteomalacia.","volume":"294","author":"Jan de Beur","year":"2005","journal-title":"JAMA"},{"key":"R19-10-20210207","doi-asserted-by":"crossref","first-page":"104s","DOI":"10.1111\/1523-1747.ep12540811","article-title":"Intermediate filaments as histologic markers: an overview.","volume":"81","author":"Osborn","year":"1983","journal-title":"J Invest Dermatol"},{"key":"R20-10-20210207","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1055\/s-2007-996971","article-title":"Experiences with hemangiopericytoma in cranial base surgery.","volume":"77","author":"Schick","year":"1998","journal-title":"Laryngorhinootologie"},{"key":"R21-10-20210207","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s10006-005-0649-x","article-title":"Hemangiopericytoma (extrapleural solitary fibrous tumour). Exemplified and discussed on the basis of two cases.","volume":"9","author":"Wilde","year":"2005","journal-title":"Mund Kiefer Gesichtschir"},{"key":"R22-10-20210207","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0950-351X(96)80362-4","article-title":"Somatostatin receptors and disease: role of receptor subtypes.","volume":"10","author":"Hofland","year":"1996","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"R23-10-20210207","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002560050581","article-title":"Oncogenic osteomalacia.","volume":"29","author":"Sundaram","year":"2000","journal-title":"Skeletal Radiol"},{"key":"R24-10-20210207","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1200\/JCO.2005.05.043","article-title":"Oncogenic osteomalacia associated with hemangiopericytoma localized by octreotide scan.","volume":"23","author":"Auethavekiat","year":"2005","journal-title":"J Clin Oncol"},{"key":"R25-10-20210207","first-page":"326","article-title":"Malignant hemangioperiytomas in the head and neck area.","volume":"38","author":"Weber","year":"1990","journal-title":"HNO"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00124743-200901000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:02:09Z","timestamp":1618038129000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00124743-200901000-00010"}},"subtitle":["Successful Treatment by Radio-Guided Tumor Surgery"],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e3181960483","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}